1.The Role of Oriental Medicine in the Great East Japan Earthquake Disaster
Shin TAKAYAMA ; Reina OKITSU ; Koh IWASAKI ; Masashi WATANABE ; Tetsuharu KAMIYA ; Atsushi HIRANO ; Ayane MATSUDA ; Yasutake MONMA ; Takehiro NUMATA ; Hiroko KUSUYAMA ; Sou HIRATA ; Akiko KIKUCHI ; Takashi SEKI ; Takash TAKEDA ; Nobuo YAEGASHI
Kampo Medicine 2011;62(5):621-626
The Great East Japan earthquake and tsunami disaster that occurred on March 11, 2011 seriously destroyed Japanese social activities the medical system included. We provided medical support to the damaged area, and mainly performed Oriental medicine. Traditional methods using physical diagnoses and the treatments with herbs, acupuncture, and massage were effective, where any infrastructure had suffered or any modern medical facilities had been destroyed. Acute phase infectious disease, common colds, and hypothermia were dominant. Allergies increased two weeks later, and there was much mental distress, and chronic pain symptoms one month later. We prescribed Kampo herbal medicines for common colds, hypothermia, allergies, and mental distress. Moreover, we also performed acupuncture and kneaded patients' body to reduce pain, stiffness, and edema. These treatments were effective for both physical and mental distress. Thus we believe that Oriental medicine is valuable in disaster situations.
2.Retrospective analysis of sites of recurrence in stage I epithelial ovarian cancer.
Sou HIROSE ; Hiroshi TANABE ; Youko NAGAYOSHI ; Yukihiro HIRATA ; Chikage NARUI ; Kazuhiko OCHIAI ; Seiji ISONISHI ; Hirokuni TAKANO ; Aikou OKAMOTO
Journal of Gynecologic Oncology 2018;29(3):e37-
OBJECTIVE: The aim of the study is to investigate recurrence of stage I epithelial ovarian cancer. METHODS: Six hundred two patients diagnosed with stage I epithelial ovarian cancer at 4 hospitals between 2000 and 2013 were retrospectively analyzed. Age, surgical procedure, substage, histologic type, adjuvant chemotherapy, recurrence, initial recurrence site (peritoneal dissemination [P], hematogenous recurrence [H], lymphogenous recurrence [L], and others [O]), and frequency of recurrence at each site were investigated retrospectively. RESULTS: Median age was 54 years and median follow-up was 60 months. The stage was IA in 180 cases (30%), IB in 8 (1%), IC1 in 247 (41%), IC2 in 63 (10%), and IC3 in 104 (17%). Systematic lymph node dissection including both pelvic and para-aortic lymph nodes was performed in 224 patients (37%), and 412 patients (68%) received adjuvant chemotherapy. Recurrence occurred in 70 patients (11.6%). The median time to recurrence was 18 months, and the stage was IA in 13 (19%), IB in 1 (1%), IC1 in 24 (34%), IC2 in 9 (13%), and IC3 in 23 (33%) cases. The numbers of recurrence at the P, H, L, and O sites, including overlapping cases, were 49 (70%), 18 (26%), 9 (13%), and 6 (9%), respectively, and recurrence by peritoneal dissemination in the pelvis occurred in 43 cases (61%). CONCLUSION: Recurrence of stage I epithelial ovarian cancer by peritoneal dissemination was frequent, especially in the pelvis. There is a need to elucidate the pathogenesis of peritoneal recurrence and to prepare a treatment strategy to prevent pelvic peritoneal recurrence.
Chemotherapy, Adjuvant
;
Follow-Up Studies
;
Humans
;
Lymph Node Excision
;
Lymph Nodes
;
Neoplasm Metastasis
;
Neoplasm Seeding
;
Ovarian Neoplasms*
;
Pelvis
;
Recurrence*
;
Retrospective Studies*